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Abstract
Adenosine neuromodulation depends on a balanced activation of inhibitory A1 (A1R) and facilitatory A2A receptors (A2AR). Both A1R
and A2AR modulate hippocampal glutamate release and NMDA-dependent long-term potentiation (LTP) but ageing affects the
density of both A1R and A2AR. We tested the effects of selective A1R and A2AR antagonists in the modulation of synaptic
transmission and plasticity in rat hippocampal slices from three age groups (young adults, 2–3 month; middle-aged adults,
6–8 months; aged, 18–20 months). The selective A2AR antagonist SCH58261 (50 nm) attenuated LTP in all age groups, with a larger
effect in aged ()63 ± 7%) than in middle-aged adults ()36 ± 9%) or young adult rats ()36 ± 9%). In contrast, the selective A1R
antagonist DPCPX (50 nm) increased LTP magnitude in young adult rats (+42 ± 6%), but failed to affect LTP magnitude in the other
age groups. Finally, in the continuous presence of DPCPX, SCH58261 caused a significantly larger inhibition of LTP amplitude in
aged ()71 ± 45%) than middle-aged ()28 ± 9%) or young rats ()11 ± 2%). Accordingly, aged rats displayed an increased
expression of A2AR mRNA in the hippocampus and a higher number of glutamatergic nerve terminals equipped with A2AR in aged
(67 ± 6%) compared with middle-aged (34 ± 7%) and young rats (25 ± 5%). The results show an enhanced A2AR-mediated
modulation of LTP in aged rats, in accordance with the age-associated increased expression and density of A2AR in glutamatergic
terminals. This age-associated gain of function of A2AR modulating synaptic plasticity may underlie the ability of A2AR antagonists to
prevent memory dysfunction in aged animals.
Introduction
Adenosine is a neuromodulator in the central nervous system by
mainly activating inhibitory A1 receptors (A1R) and facilitatory A2A
receptors (A2AR) (reviewed in Fredholm et al., 2005). Adenosine
mainly acts at the synaptic level, inhibiting the release of glutamate
and postsynaptic responsiveness and predominantly modulates excit-
atory rather than inhibitory synapses (Fredholm et al., 2005). There
seems to be a segregation of the role of A1R and A2AR in excitatory
synapses, which seems to depend on the source of extracellular
adenosine (reviewed in Cunha, 2008) – A1R are activated by purines
originated from astrocytes (Pascual et al., 2005) and efﬁciently
inhibit basal synaptic transmission and synaptic plasticity phenomena
that are dependent on more integrated properties of the neuronal
network (Sta¨ubli & Chun, 1996; Fujii et al., 1999; Huang et al.,
1999; de Mendonc¸a & Ribeiro, 2001; Izumi & Zorumski, 2008). In
contrast, A2AR play a prominent facilitatory role in homo-synaptic
plasticity phenomena (Rebola et al., 2008; Fontinha et al., 2009).
This ability of A2AR to enhance the activity-dependent efﬁciency of
excitatory synapses has been argued to result from an enhanced
release of neurotransmitters (Lopes et al., 2002; Rebola et al.,
2003b), from a localized desensitization of A1R-mediated inhibition
(Lopes et al., 1999; reviewed in Cunha, 2008), from a facilitation of
brain-derived neurotrophic factor-induced signalling (Fontinha et al.,
2008) and from an enhanced responsiveness of N-methyl-d-aspartate
(NMDA) receptors (Rebola et al., 2008). It is likely that all these
mechanisms contribute to the modulation of synaptic plasticity by
A2AR, under different functional conditions or at different excitatory
synapses.
Interest in the modulation of synaptic plasticity by adenosine is
prompted by the combined arguments that synaptic plasticity phe-
nomena may be a neurophysiological correlate of learning and memory
(Martin et al., 2000; Govindarajan et al., 2006) and that caffeine (an
antagonist of adenosine receptors, see Fredholm et al., 1999) can
modify cognitive function (reviewed in Cunha & Agostinho, 2010). In
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fact, the chronic consumption of caffeine is particularly effective in
preventing cognitive dysfunction caused by different noxious insults
(de Mendonc¸a & Cunha, 2010), in a manner mimicked by A2AR but
not A1R antagonists (e.g. Prediger et al., 2005; Dall’Igna et al., 2007).
Although it has not been clariﬁed how caffeine and A2AR antagonists
control memory dysfunction, it is hypothesized that this might result
from an A2AR-mediated modulation of synaptic function, given that
both A1R and A2AR are most abundantly located in excitatory
synapses in cortical regions (Rebola et al., 2003a; Rebola et al.,
2005a,b).
It is not only under pathological conditions that caffeine and A2AR
antagonists have the ability to normalize memory function. Ageing is
also accompanied by cognitive deterioration, which we have found to
be attenuated by caffeine consumption (Ritchie et al., 2007). This is
also observed in experimental animals, where both caffeine and A2AR
antagonists prevent age-related memory deﬁcits (Prediger et al., 2005;
Costa et al., 2008). Interestingly, we also observed an imbalance
between markers of excitatory and inhibitory terminals in the
hippocampus of aged rats (Canas et al., 2009), which is accompanied
by an up-regulation of A2AR and a down-regulation of A1R (e.g.
Cunha et al., 1995; Canas et al., 2009). We have previously found that
this corresponds to a modiﬁed modulation of hippocampal synaptic
transmission by A1R and A2AR (e.g. Sebastia˜o et al., 2000; Rebola
et al., 2003b). However, it is not known if there is also a different
ability of adenosine receptors to modulate synaptic plasticity phe-
nomena in aged rodents (see Costenla et al., 1999). This is particularly
relevant in view of the distinctive ability of A1R and A2AR to
modulate basal synaptic transmission and synaptic plasticity (reviewed
in Cunha, 2008). In this study, we investigated in Schaffer ﬁbre–CA1
pyramid synapses if the activation of A1R and A2AR by endogenous
adenosine differently modulates synaptic plasticity in young adult,
middle-aged and aged rats.
Materials and methods
Animals
Experiments were performed in male Wistar rats (Harlan Interfauna
Iberica, Barcelona, Spain) divided into three age groups: young adult
rats (2–3 months, an age at which reproductive behaviour is fully
established), middle-aged adult rats (6–8 months) and aged rats (18–
20 months) (see Havenaar et al., 1993). The animals were handled
according to EU guidelines for the use of experimental animals
(86 ⁄ 609 ⁄ EEC), the rats being anaesthetized under halothane atmo-
sphere before being killed by decapitation.
Drugs
As the goal of this study was to characterize the modiﬁcation with
ageing of the activation of A1R and A2AR by endogenous adenosine,
we used a selective antagonist of each of these receptors, namely
DPCPX (1,3-dipropyl-8-cyclopentylxanthine; Sigma) and SCH58261
{7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazol-
ol[1,5c] pyrimidine; a generous gift of S. Weiss, Vernalis, UK}. We
have previously characterized the efﬁcacy and selectivity of each of
these antagonists for A1R and A2AR in the hippocampus (Sebastia˜o
et al., 1990; Rebola et al., 2003b; Lopes et al., 2004). We used a
supra-maximal but selective concentration of DPCPX (50 nm) and
of SCH58261 (50 nm) to deﬁne the role of each receptor in mediating
the effects of endogenous extracellular adenosine. A 5 mm stock
solution of these antagonists was prepared in dimethylsulfoxide, and
dissolved in Krebs solution to a concentration of 50 nm.
Electrophysiological recordings
One 400-lm hippocampal slice, obtained as previously described (e.g.
Costenla et al., 2001), was transferred to a 1-mL recording chamber
for submerged slices and continuously superfused, at a ﬂow rate of
3 mL ⁄min, with gassed (95% O2 and 5% CO2) Krebs solution, kept at
30 C, with the following composition (in mm): 125 NaCl, 3 KCl,
1.25 NaH2PO4, 25 NaHCO3, 2 CaCl2, 1 MgSO4 and glucose 10 (pH
7.4). Electrophysiological recordings of ﬁeld excitatory postsynaptic
potentials (fEPSPs) were obtained as previously described (e.g.
Costenla et al., 1999). Two bipolar concentric electrodes placed on
two separate sets of the Schaffer collateral ⁄ commissural pathway (S1
and S2) were alternately stimulated every 20 s with rectangular pulses
of 0.1 ms. Orthodromically evoked fEPSPs were recorded through an
extracellular microelectrode (4 m NaCl, 2–5 mX resistance) placed in
the stratum radiatum of the CA1 area. The intensity of the stimulus
was adjusted to evoke an fEPSP with an amplitude of 0.5–1 mV
without appreciable population spike contamination at the beginning
of the experiment, although population spike contamination often
occurred during the experiment as a result of modiﬁcation of
transmission and excitability. Recordings were obtained with an
Axoclamp 2B ampliﬁer and digitized using a DigiData 1200 interface
(Axon Instruments, Foster City, CA, USA). Averages of eight
consecutive responses from each pathway were continuously moni-
tored on a personal computer with ltp 1.01 software (Anderson &
Collingridge, 2001). Responses were quantiﬁed as the initial slope of
the averaged fEPSPs and the effects of drugs (DPCPX and ⁄ or
SCH58261), added to the superfusion solution, were estimated based
on changes in the fEPSP slope compared with baseline. The
independence of the pathways was tested by studying paired-pulse
facilitation across both pathways, < 10% facilitation being usually
observed (Costenla et al., 1999).
Long-term potentiation (LTP) was induced by a high-frequency
stimulation pattern (HFS, one train of 100 Hz, 100 stimuli). The
intensity of the stimulus was not changed during these stimulation
protocols, which were applied after reaching a stable baseline for at
least 30 min. LTP was quantiﬁed as the percentage change between
two values: the average slope of the ﬁve potentials taken between 50
and 60 min after the induction protocol in relation to the average
slope of the fEPSP measured during 15 min that preceded the
induction protocol. LTP was elicited in one pathway under control
conditions, and afterwards in the other pathway in the presence of
the drugs to be tested. We have previously optimized the
experimental conditions ensuring similar amplitudes of LTP in these
two pathways recorded in the same hippocampal slice (e.g. Costenla
et al., 1999, 2001). Thus, the effects of SCH58261 or DPCPX on
LTP were evaluated by comparing the magnitude of LTP in the ﬁrst
pathway in the absence of drugs (control pathway) with the
magnitude of LTP in the second pathway in the presence of the
adenosine receptor antagonists (test pathway). The drugs were added
at least 30 min before applying the HFS train to the test pathway and
were present throughout the rest of the experiment. When we tested
if the effect of SCH58261 was modiﬁed by blockade of A1R,
DPCPX was present during both LTP-inducing periods (i.e.
throughout all the experiment), whereas SCH58261 was added only
30 min before the induction of LTP in the test pathway. This type of
protocol allows direct comparison of the effect of a tested drug with
an internal control in the same slice in the absence of this tested
drug. Care was always taken to change the control and test pathways
on alternate days to avoid any bias. Clearly the aim of this study was
to explore differences of adenosine receptor modulation on LTP
across different aged groups rather than exploring whether this
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speciﬁc LTP protocol triggers a different pattern of LTP in the
different age groups.
Input ⁄ output curves, in the different age groups, were obtained to
ensure that modiﬁcations of LTP amplitude were not due to changes in
baseline synaptic efﬁciency. After obtaining a stable baseline for at
least 15 min, the input delivered to the slice was decreased until the
slope of the fEPSP was virtually zero. Then, the current delivered to
the slice was increased by steps of 20 lV and three data points were
collected at each stimulation amplitude (each data point being the
average of eight individual fEPSPs). The range of all the inputs
delivered to the slice was typically from 60 lV to a supramaximal
stimulation amplitude of 300 lV. The input ⁄ output curves were
plotted as the relationship of fEPSP slope versus stimulus intensity
(i.e. ﬁber volley amplitude), which provides a measure of synaptic
efﬁciency.
Analysis of A1 and A2A receptor expression
One hippocampus per rat was used to extract total RNA with a
MagNA Lyser Instrument and a MagNA Pure Compact RNA
Isolation kit (Roche, Amadora, Portugal), according to the manufac-
turer’s instructions. The integrity, quantity and purity of the RNA
yields were checked by electrophoresis and spectrophotometry.
Reverse transcription for ﬁrst-strand cDNA synthesis from each
sample was performed using a random hexamer primer with the
Transcriptor First Strand cDNA Synthesis kit (Roche), according to
the manufacturer’s instructions. The resulting cDNAs were used
as templates for real-time polymerase chain reaction (PCR), which
was carried out on a LightCycler instrument (Roche) using the
FastStart DNA Master SYBR Green I kit (Roche). A2AR and A1R
mRNA expression was calculated relative to b-actin mRNA expres-
sion, using the following primers (obtained from Tib MolBiol, Berlin,
Germany): A2AR (forward: 5¢-AGTCAGAAAGACGGGAAC-3¢;
reverse: 5¢-CAGTAACACGAACGCAA-3¢), A1R (forward: 5¢-GGA-
TCGATACCTCCGAGTCA-3¢; reverse: 5¢-GAGAATCCAGCAGC-
CAGCTA-3¢). Quantiﬁcation was carried out based on standard
curves run simultaneously with the test samples, with A2AR, A1R and
b-actin standards being generated by conventional PCR ampliﬁcation,
as previously described (Duarte et al., 2007). The PCR products were
run in a 3% agarose gel electrophoresis to verify fragment size and the
absence of other contaminating fragments, estimated by absorbance at
260 nm, and serially diluted to produce the standard curve (90–
112 copies ⁄ lL). Each real-time PCR reaction was run in triplicate and
contained 2 lL of cDNA template, 0.3 lm of each primer, and
3.5 mm MgCl2 in a reaction volume of 20 lL. Cycling parameters
were: 95 C for 10 min to activate DNA polymerase, followed by 40
cycles at 95 C for 10 s, annealing at 60 or 65 C for 10 s (for A2AR
and A1R, respectively), and a ﬁnal extension step at 72 C for 10 s, in
which ﬂuorescence was acquired. The purity and speciﬁcity of the
resulting PCR products were assessed by melting curve analysis and
electrophoresis. Control reactions were performed to verify that no
ampliﬁcation occurred without cDNA.
Immunocytochemical analysis of A1R and A2AR in glutamatergic
nerve terminals
Hippocampal nerve terminals were puriﬁed through a discontinuous
Percoll gradient and plated over poly-l-lysine-coated cover-slips for
immunocytochemical analysis, using previously validated antibodies
(e.g. Rodrigues et al., 2008). Permeabilized nerve terminals were
incubated for 1 h with guinea pig anti-vesicular glutamate transporters
(vGluT1) (1 : 1000; Chemicon, Temecula, CA, USA) and either rabbit
anti-A1R (1 : 200; Afﬁnity Bioreagent, Rockford, IL, USA) or goat
anti-A2AR (1 : 200; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), followed by 1 h of incubation with AlexaFluor-labelled
secondary antibodies (1 : 2000; Molecular Probes, Leiden, the
Netherlands). We also checked that the antibodies against A1R or
against A2AR did not yield any signal in the preparation from each
adenosine receptor knockout mouse and the antibody against vGluT1
did not label any element labelled by markers of GABAergic,
cholinergic or dopaminergic markers in hippocampal nerve terminals,
thus suggesting their selective ability to recognize their purported
targets in rat hippocampal nerve terminals. After washing and
mounting onto slides with Prolong Gold Antifading (Invitrogen,
Eugene, OR, USA), preparations were visualized in a Zeiss Axiovert
200 inverted ﬂuorescence microscope. Digital photomicrographs were
obtained using a PlanNeoﬂuar oil objective with 100 · magniﬁcation
and 1.30 numerical aperture and acquired with a cooled CCD digital
camera. As the ﬂuorophores linked to secondary antibodies emitted at
different wavelengths, different images of the same ﬁeld are acquired
for each ﬂuorophore by rotating the ﬁlter wheel of the microscope.
The following ﬁlter sets were used for the acquisition: set 38
(excitation – BP 470 ⁄ 40, beam splitter FT 495, emission – BP525 ⁄ 50)
for Alexa Fluor 488 and set 31 (excitation – BP 565 ⁄ 30, beam splitter
FT 585, emission – BP620 ⁄ 60) for Alexa Fluor 594. It was conﬁrmed
that none of the secondary antibodies produced any signal in
preparations in which the addition of the corresponding primary
antibody was omitted. Most importantly, it was conﬁrmed that
individual signals in double-labelled ﬁelds are not enhanced over the
signals under single-labelling conditions. The exposure time for
vGluT1 ranged between 100 and 125 ms and between 150 and
200 ms for A1R and A2AR, depending on the density of the targeted
protein in the observed coverslip. The images, acquired in TIFF
format, had the following characteristics: dimensions of 1024 · 767
pixels, resolution of 150 pixels per inch with 32 RGB bits per pixel
and a depth ⁄ colour pixel relation of 24 ⁄ 16 million. Each coverslip
was analysed by counting three different ﬁelds and in each ﬁeld a total
of 500 individualized elements, as previously described (Rodrigues
et al., 2008). It should be noted that we can never guarantee to achieve
plating similar amounts of nerve terminals in each experiment. This is
minimized by gently suspending (rather than homogenizing) the nerve
terminals until reaching an optical density of 0.055, which provides
the best relationship between the number of nerve terminals per
coverslip and a minimum number of nerve terminal aggregates, which
are discarded from analysis. Hence, no conclusion should be drawn by
comparing the number of plated nerve terminals in each experiment.
The acquired images were quantiﬁed using a Java-based image
processing program, Imagej 1.37v (NIH, Bethesda, MD, USA), to
determine the co-localization of the different ﬂuorophores in the plated
nerve terminals using a macro developed by us and validated through
manual counting (Rodrigues et al., 2008). Brieﬂy, the recorded images
of the same ﬁeld were grouped according to the ﬂuorophore ⁄ colour
and converted to black and white images. Thresholding was performed
using Otsu’s method and the ‘rolling ball’ algorithm was applied when
the background was heterogeneous, both applied equally in all images
from the same ﬁeld. We then applied a counting mask, corresponding
to an 8-bit black-and-white analysis, with characteristics adapted to the
expected morphological characteristics of nerve terminals, namely to
include only particles with a minimum dot size of 4 pixels, a
maximum dot size of 25 pixels and a circularity of 0.0–1.0. The
individual images from each ﬁeld were treated with the same settings
and the total number of particles labelled with each ﬂuorophore
counted using the same mask parameters; as the coordinates of each
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particle are recorded, this enables us to detect the co-localization of
each ﬂuorophore in the same ﬁeld. To ensure that putative
co-localizations do not result from superimposed nerve terminals,
we repeated this same analysis, but now using images acquired using
a Zeiss LSM Meta confocal microscope and we concluded that
superimposition of particles accounts for < 3% of the estimated
co-localization of different ﬂuorophores.
Statistics
Values are presented as mean ± SEM of n different animals. As the
values for fEPSP slope and LTP magnitude were obtained in the
same slices, in the absence and in the presence of a speciﬁc drug, a
mixed repeated-measures analysis of variance (anova) was the most
appropriate statistical test, using control solution and drug as the
within-subjects condition, and the age group as the between-subjects
condition; if a drug · age group interaction was found signiﬁcant,
post-hoc comparisons for the three age groups were done with Fisher’s
least-signiﬁcant difference (LSD) test. For the analysis of the impact
of ageing on the expression of adenosine receptors and of the
association of adenosine receptors to glutamatergic nerve terminals,
we ﬁrst carried out a one-way anova and compared the mean values
of the each group using the Newman–Keuls test. Unless otherwise
speciﬁed, values of P £ 0.05 were considered to be statistically
signiﬁcant. All statistical analyses were performed with spss (v. 19.0;
IBM SPSS Inc., Chicago, IL, USA).
Results
Input ⁄ output curves determined in two age groups (2–3 and 18–
20 months old) were super-imposable (Fig. 1), indicating that changes
in synaptic strength were unlikely to be responsible for eventual LTP
differences among the age groups.
Effects of the A2AR antagonist, SCH58261, on LTP
We used a selective antagonist of A2AR, SCH58261, to probe the role
of the tonic activation by endogenous adenosine of A2AR in the
modulation of synaptic transmission and plasticity. The supra-maximal
concentration of 50 nm was used to block virtually all adenosine
A2AR, but maintaining the selectivity towards other adenosine
receptor subtypes (see Lopes et al., 2004). Under low-frequency
stimulation (0.05 Hz), SCH58261 (50 nm) slightly increased the slope
of fEPSPs in hippocampal slices from young adult rats by 11.9 ± 4.3%
(n = 8), in middle-aged adult rats by 8.0 ± 4.0% (n = 6) and in aged
rats by 6.0 ± 5.1% (n = 5) (non-signiﬁcant effects, F1,16 = 3.19,
P > 0.05, repeated-measures anova) (Fig. 2A).
In contrast to the lack of signiﬁcant effects under low-frequency
stimulation, SCH58261 (50 nm) consistently decreased the magnitude of
HFS-induced (100 Hz for 1 s) LTP in all age groups (Fig. 2). In young
adult rats, the magnitude of LTP was decreased from 51.4 ± 7.9% in
control conditions to 32.0 ± 1.9% in the presence of SCH58261 (n = 8,
Fig. 2B and C), which corresponds to a 37.7 ± 8.3% reduction of LTP
amplitude by SCH58261. In middle-aged adult rats, the magnitude of
LTP was decreased from 73.4 ± 3.4% in control conditions to
45.4 ± 6.0% in the presence of SCH58261 (n = 6, Fig. 2B and D),
which corresponds to a 36.2 ± 9.1% reduction of LTP amplitude by
SCH58261. In aged rats, the magnitude of LTP was decreased from
80.9 ± 7.4% in control conditions to 28.1 ± 4.4% in the presence of
SCH58261 (n = 5, Fig. 2B and E), which corresponds to a 63.4 ± 6.9%
reduction of LTP amplitude by SCH58261. Thus, the selective A2AR
antagonist SCH58261 decreased LTP (F1,16 = 41.2, P < 0.001, re-
peated-measures anova), an effect that was marginally dependent upon
age (interaction between age group and drug effect, F2,16 = 3.54,
P = 0.05), being more pronounced in aged rats than young rats
(P = 0.04, post-hoc LSD test), and in middle-aged rats than young rats
(P = 0.005, post-hoc LSD test).
It should be noted that fEPSPs recorded from slices of old rats
tended to be more contaminated with population spikes that fEPSPs
recorded from slices of young adult rats, and this was particularly
evident after LTP induction (e.g. Fig. 2C). However, none of the slices
displayed epileptogenic-like activity before LTP induction. The
surgical disconnection between the CA3 and CA1 regions failed to
affect either the magnitude of LTP or the degree of contamination of
the fEPSPs after LTP induction both in young adult and in aged rats
(not shown); this suggests that this experimentally evoked process is
independent of spontaneous activity emerging from the CA3 area
circuitry. Thus, the greater excitability observed after LTP induction in
aged rats might result from different intrinsic neuronal properties or
local circuit modiﬁcations, such as rheobase properties of CA1
pyramids (Potier et al., 1992; see Barnes, 1994) or lower GABAergic
inhibition (Billard et al., 1995) in aged rats.
Effects of the selective A1R antagonist, DPCPX, on LTP
As the A2AR signalling mechanism changes upon ageing from mainly
counteracting A1R-mediated inhibition in young adults (Lopes et al.,
1999, 2002) to a direct facilitatory effect independent of A1R in aged
animals (Rebola et al., 2003b), we next tested if the inhibitory effects of
SCH58261 on LTPmight result from a modiﬁed tonic activation of A1R.
We used the selective antagonist of A1R, DPCPX, to probe the role
of the tonic activation by endogenous adenosine of A1R in the
modulation of synaptic transmission and plasticity; a supra-maximal
concentration of 50 nm of DPCPX was used to block virtually all
A1R, but maintaining the selectivity towards other adenosine receptor
Fig. 1. Input–output curves obtained in hippocampal slices of young adult rats
(2–3 months old) and aged rats (18–20 months old) are nearly super-
imposable. Input ⁄ output curves are displayed as the relationship between
fEPSP slope (ordinates) and stimulus intensity (measured as the amplitude of
the presynaptic volley, in the abscissa) in the two age groups. After obtaining a
stable baseline for at least 15 min, the input delivered to the slice was decreased
until the slope of the fEPSP was virtually zero. Afterwards, the current
delivered to the slice was increased in steps of 20 lV, with three data points
collected at each stimulation amplitude (each data point being the average of
eight individual fEPSPs). The range of all the inputs delivered to the slice was
typically from 60 lV to a supramaximum stimulation amplitude of 300 lV.
Data are mean ± SEM (both of ﬁbre volley and fEPSP slope in each data point)
of n = 3 rats.
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subtypes (see Sebastia˜o et al., 2000). In hippocampal slices from
young adult rats, DPCPX (50 nm) increased the slope of fEPSPs by
35.0 ± 6.7% (n = 7), in middle-aged adult rats by 30.7 ± 5.4%
(n = 5) and in aged rats by 27.5 ± 8.1% (n = 4). The excitatory
effect of DPCPX (50 nm) on fEPSPs slope was statistically signiﬁcant
(F1,11 = 93.95, P < 0.001, repeated-measures anova), but was not
modiﬁed by the age of the rats (interaction between age group and
drug effect, F2,11 = 0.33, P > 0.05) (Fig. 3A).
The effect of DPCPX (50 nm) on the magnitude of LTP was studied
in the three age groups. In young adult rats, the magnitude of LTP was
46.8 ± 5.2% in control conditions and increased to 80.9 ± 4.0% in the
presence of DPCPX (n = 6, Fig. 3B and C). In middle-aged adult rats,
the magnitude of LTP was 67.4 ± 5.4% in control conditions and
74.1 ± 8.8% in the presence of DPCPX (n = 5, Fig. 3B and D), and in
aged rats the magnitude of LTP was 86.7 ± 5.5% in control conditions
and 89.9 ± 9.7% in the presence of DPCPX (n = 4; Fig. 3B and E).
Thus, the selective A1R antagonist DPCPX (50 nm) increased LTP
(F1,14 = 11.93, P = 0.004, repeated-measures anova), an effect that
was dependent upon age (interaction between age group and drug
effect, F2,14 = 6.33, P = 0.01), tending to be more pronounced in
young than in aged rats (P = 0.06, post-hoc LSD test).
Effects of the A2AR antagonist, SCH58261, on LTP under A1R
blockade
Finally, to determine if the effects of A2AR on LTP might result from
an interaction with A1R, we tested the effect of SCH58261 (50 nm) on
the magnitude of LTP in the presence of DPCPX (50 nm) to block
A1R. In these experiments, control LTP was elicited in the presence of
DPCPX (50 nm), whereas the test LTP was carried out in the
simultaneous presence of DPCPX (50 nm) and SCH58261 (50 nm).
As occurred in the absence of A1R blockade, SCH58261 (50 nm) had
only slight effects on basal synaptic transmission in the presence of
DPCPX (50 nm) in hippocampal slices from either young adult
(4.7 ± 2.9%, n = 5), middle-aged adult (0.6 ± 7.3%, n = 6) or aged
rats (6.7 ± 3.8%, n = 6) (non-signiﬁcant effects, F1,14 = 0.71,
P > 0.05, repeated-measures anova) (Fig. 4A).
Upon blockade of A1R with DPCPX (50 nm), we also observed
an inhibitory effect of SCH58261 (50 nm) on the magnitude of LTP
(Fig. 4). In young adult rats, the magnitude of LTP was
83.3 ± 12.8% in the presence of DPCPX and 73.9 ± 8.9% in the
simultaneous presence of DPCPX and SCH58261 (n = 5, Fig. 4B
and C). In middle-aged adult rats, the magnitude of LTP was
81.1 ± 8.1% in the presence of DPCPX and 58.2 ± 10.6% in the
simultaneous presence of DPCPX and SCH58261 (n = 6, Fig. 4B
and D), which corresponds to a 27.8 ± 9.4% reduction of LTP
magnitude by SCH58261 in the presence of DPCPX. In aged rats,
the magnitude of LTP was 90.2.0 ± 6.8% in control conditions and
24.8 ± 2.7% in the presence of SCH58261 (n = 4, Fig. 4B and E),
which corresponds to a 71.1 ± 4.4% reduction of LTP magnitude by
SCH58261 in the presence of DPCPX. Thus, the selective A2AR
antagonist SCH58261 (50 nm) decreased LTP in the presence
of DPCPX (50 nm) (F1,13 = 18.54, P = 0.001, repeated-measures
anova), an effect that was dependent upon age (interaction between
age group and drug effect, F2,13 = 3.86, P = 0.048), being more
A B
C D E
Fig. 2. Adenosine A2A receptors (A2AR) modulate synaptic plasticity throughout the age of the animals. (A) The effect of the selective A2AR antagonist SCH 58261
(50 nm) on basal fEPSP amplitude; (B) the magnitude of LTP (change in fEPSP slope at 50–60 min) induced by a high-frequency stimulation (HFS) train in relation
to pre-HFS values (0%) in the absence (control) or in the presence of SCH 58261 (50 nm). All values are mean ± SEM; **P < 0.05 repeated-measures anova for
the effect of SCH 58261 (50 nm); there was a marginally signiﬁcant interaction between age group and drug effect; *post-hoc comparisons of the effects of SCH
58261 (50 nm) on LTP in different age groups using Fisher’s LSD test. (C–E) Averaged time course changes of fEPSP slope induced by HFS in the absence or in the
presence of SCH 58261 (50 nm) in hippocampal slices taken from 2–3 (A, n = 8), 6–8 (B, n = 6) and 18–20 (C, n = 5) month-old rats. SCH 58261 (50 nm) was
applied 30 min before the LTP induction in the second pathway and remained in the bath up to the end of the experiment. The ordinates represent normalized fEPSP
slopes where 0% corresponds to the averaged slopes recorded for 15 min before the HFS and the abscissa represents the time of each recording. Recordings obtained
in representative experiments are shown below each panel; each recording is the average of eight consecutive responses obtained before (dotted line) and 50–60 min
after (ﬁlled line) LTP induction in the presence or in the absence (control) of SCH 58261 (50 nm); each trace comprises the stimulus artefact, followed by the
presynaptic volley and the fEPSP.
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pronounced in aged than in young rats (P = 0.04, post-hoc LSD
test).
Age-dependent modification of the expression and density of
A1R and A2AR in glutamatergic terminals
In accordance with the previously observed age-associated decrease
of the density of A1R and increase of the density of A2AR in the
hippocampus (Cunha et al., 1995; Canas et al., 2009), we now
report that ageing caused a reduced expression of A1R mRNA
(F2,12 = 4.718, P = 0.0308, one-way anova), with aged rats
displaying less A1R mRNA than young adult rats (P < 0.05, post-
hoc Newman–Keuls test with q = 4.323, corresponding to a
24.3 ± 2.6% decrease, n = 5). In contrast, ageing enhanced the
expression of A2AR mRNA in aged rats (F2,12 = 23.45, P < 0.0001,
one-way anova), with aged rats displaying more A2AR mRNA
than middle-aged (P < 0.05, post-hoc Newman–Keuls test with
q = 8.786) or young adult rats (P < 0.05, post-hoc Newman–Keuls
test with q = 7.923, corresponding to a 103.4 ± 10.9% increase,
n = 5) (Fig. 5A and B).
We next investigated if aged animals displayed a different
association of A1R and A2AR with glutamatergic nerve terminals of
the hippocampus that could explain the observed age-related changes
in the efﬁciency of A1R and A2AR modulating the functioning of
glutamatergic synapses. As shown in Fig. 5C–F, the association of
A2AR, but not of A1R, with glutamatergic synapses was modiﬁed in
aged rats. Thus, the number of glutamatergic terminals (identiﬁed as
immunopositive for vGluT1) endowed with A1R was similar
(F2,9 = 0.1797, P = 0.8384, one-way anova comparing the different
age groups) in young adult rats (71.2 ± 12.7%, n = 4), in middle-aged
rats (59.6 ± 15.2%, n = 4) and in aged rats (63.1 ± 13.5%, n = 4). In
contrast, there was an age-related increase of A2AR immunoreactivity
in vGluT1-positive terminals (F2,15 = 17.41, P < 0.0001, one-way
anova): in young adult rats 25.3 ± 3.9% (n = 6) of vGluT1-positive
terminals were endowed with A2AR and a similar number was present
in middle-aged rats (33.7 ± 6.9%, n = 6, P > 0.05, q = 1.559, post-
hoc Newman–Keuls test), whereas in aged rats the number of
glutamatergic terminals endowed with A2AR was increased to
66.8 ± 5.8% (n = 6), which was larger than for the middle-aged
(P < 0.05, q = 6.321, post-hoc Newman–Keuls test) and young adult
groups (P < 0.05, q = 7.880, post-hoc Newman–Keuls test).
Discussion
The main conclusion of this study is that the ability of adenosine to
modulate hippocampal LTP through activation of adenosine A2AR is
observed from young to aged animals and is more pronounced in aged
animals. This is accompanied by an age-related increase of the
expression of A2AR mRNA in the hippocampus, in agreement with the
previously reported increased density of A2AR in the hippocampus of
aged rats (Cunha et al., 1995; Canas et al., 2009); furthermore, we
now report that there is an increased number of glutamatergic nerve
A
C D E
B
Fig. 3. Adenosine A1 receptors (A1R) only modulate synaptic plasticity in hippocampal slices taken from young adult rats. (A) The effect of the selective A1R
antagonist DPCPX (50 nm) on basal fEPSP amplitude; (B) the magnitude of LTP (change in fEPSP slope at 50–60 min) induced by a high-frequency stimulation
(HFS) train in relation to pre-HFS values (0%) in the absence (control), or in the presence of DPCPX (50 nm). All values are mean ± SEM; **P < 0.05 repeated-
measures anova for the effect of DPCPX (50 nm); the interaction between age group and drug effect on LTP was signiﬁcant; *post-hoc comparisons of the effect of
DPCPX (50 nm) on LTP in the different age groups using Fisher’s LSD test. (C–E) Averaged time course changes of fEPSP slope induced by an HFS in the absence
or in the presence of DPCPX (50 nm) in hippocampal slices taken from 2–3 (A, n = 12), 6–8 (B, n = 16) and 18–20 (C, n = 16) month-old rats. DPCPX (50 nm)
was applied 30 min before the LTP induction in the second pathway and remained in the bath up to the end of the experiment. The ordinates represent normalized
fEPSP slopes where 0% corresponds to the averaged slopes recorded for 15 min before the HFS and the abscissa represents the time of each recording. The
recordings obtained in representative experiments are shown below each panel; each recording is the average of eight consecutive responses obtained before (dotted
line) and 50–60 min after (ﬁlled line) LTP induction in the presence or in the absence (control) of DPCPX (50 nm); each trace comprises the stimulus artefact,
followed by the presynaptic volley and the fEPSP.
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terminals endowed with A2AR in the hippocampus of aged rats, which
might explain the enhanced ability of A2AR to modulate LTP in aged
rats. Although these results favour the hypothesis that the enhanced
ability of A2AR to modulate LTP in aged rats might result from an
enhanced efﬁciency of the A2AR neuromodulation system, it cannot be
excluded that age-related changes in the dynamic range of LTP might
also contribute to an enhanced impact of A2AR on LTP with ageing. In
fact, there was a tendency (which did not reach statistical signiﬁcance)
for a large LTP magnitude as well as an increased excitability after
LTP in aged rats, which could contribute to an increased efﬁciency
of the A2AR neuromodulation system.
In contrast, we observed that adenosine modulates hippocampal
LTP through activation of adenosine A1R only in young animals.
This is in agreement with our previous observations that LTP
magnitude is more affected by A1R blockade in young adult than in
aged animals (Costenla et al., 1999), although we have not detailed
possible regional differences in age-dependent modulation by A1R of
LTP magnitude (Rex et al., 2005). Interestingly, there is a selective
decrease of A1R modulation of LTP in aged rats, as the A1R-
mediated modulation by endogenous adenosine of basal synaptic
transmission was not modiﬁed with ageing. This probably results
from the previously reported decreased efﬁciency of A1R in aged
rats (Sebastia˜o et al., 2000), which is compensated for by a different
extracellular metabolism of adenosine in aged rats (Cunha et al.,
2001a) leading to different bioavailability of extracellular adenosine
to activate A1R and A2AR in hippocampal synapses of aged rats.
This decreased ability of A1R to modulate LTP magnitude in aged
rats is also in agreement with the presently observed decreased
expression of A1R mRNA in the hippocampus of aged rats. A
similar decrease of A1R mRNA expression has also been reported to
occur in the cerebral cortex (Cheng et al., 2000) and is in accordance
with the decreased density of A1R in both the hippocampus and
cerebral cortex of aged animals (Cunha et al., 1995; Canas et al.,
2009). We also observed that the number of glutamatergic nerve
terminals endowed with A1R in aged rats was maintained, indicating
that the decreased ability of A1R in the control of LTP in aged rats
may be related mostly to a possible reduction of the density of A1R
(Cunha et al., 1995, 2001b), probably also occurring in glutamater-
gic terminals. It cannot also be completely discarded that the
different impact of A1R on LTP at different ages may result from
their known inﬂuence on circuits in the CA3 area (Moore et al.,
2003), which drive the recorded CA1 synaptic activity; however, the
likeliness of such a scenario is reduced by the observation that the
surgical disconnection between the CA3 and CA1 has a limited
impact on the magnitude of LTP in slices from young adults or aged
rats.
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Fig. 4. Adenosine A2A receptors (A2AR) modulate synaptic plasticity throughout the age of the animals independently of adenosine A1 receptors (A1R). (A) The
effect of the selective A2AR antagonist SCH58261 (50 nm) on basal fEPSP amplitude, under the continuous blockade of the A1R with DPCPX (50 nm); (B) the
magnitude of LTP (change in fEPSP slope at 50–60 min) induced by high-frequency stimulation (HFS) train in relation to pre-HFS values (0%) in the presence of
DPCPX (50 nm), in the absence (control), or in the presence of SCH 58261 (50 nm). All values are mean ± SEM; **P < 0.05 repeated-measures anova for the
effect of SCH 58261 (50 nm); there was a signiﬁcant interaction between age group and drug effect, *post-hoc comparisons of the effects of SCH58261 (50 nm) on
LTP in the different age groups using Fisher’s LSD test. (C–E) Averaged time course changes of fEPSP slope induced by HFS in the presence of DPCPX (50 nm) or
in the simultaneous presence of DPCPX (50 nm) and SCH 58261 (50 nm), in hippocampal slices taken from 2–3 (A, n = 5), 6–8 (B, n = 6) and 18–20 (C, n = 4)
month-old rats. DPCPX (50 nm) was applied 30 min before the LTP induction in the ﬁrst pathway and remained in the bath up to the end of the experiment; SCH
58261 (50 nm) was applied 30 min before LTP induction in the second pathway and remained in the bath up to the end of the experiment. The ordinates represent
normalized fEPSP slopes where 0% corresponds to the averaged slopes recorded for 15 min before HFS and the abscissa represents the time of each recording. The
recordings obtained in representative experiments are shown below each panel; each recording is the average of eight consecutive responses obtained before (dotted
line) and 50–60 min after (ﬁlled line) LTP induction in the presence of DPCPX (50 nm) or in the presence of DPCPX (50 nm) plus SCH 58261 (50 nm); each trace
comprises the stimulus artefact, followed by the presynaptic volley and the fEPSP.
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It thus seems that ageing impacts differently on A2AR and A1R in
terms of their expression and density, which may underline their
different functional roles in the modulation of glutamatergic synaptic
transmission in the hippocampus of aged rats. The molecular
mechanisms of these age-related changes are still poorly understood,
as a consequence of our limited knowledge on the mechanisms
controlling the expression of A1R and A2AR and their subcellular
targeting. However, the present data further emphasize the different
functional roles of A1R and A2AR in the modulation of synaptic
transmission and synaptic plasticity (reviewed in Cunha, 2008), which
seem to be modiﬁed upon ageing. In fact, as previously shown
(Dunwiddie, 1980), the tonic activation of A1R by endogenous
adenosine modulates basal synaptic transmission; however, there does
not seem to be sufﬁcient adenosine to tonically activate A2AR under
conditions of a lower frequency of stimulation (basal conditions) (see
Cunha et al., 1997). In contrast, under conditions of HFS able to
trigger LTP, there is now a tonic activation of A2AR by endogenous
adenosine that facilitates LTP. This probably results from the particular
pool of extracellular adenosine that activates A2AR, which is formed
from synaptically released ATP (Cunha et al., 1996a; Rebola et al.,
2008) that is released in a frequency-dependent manner (Cunha et al.,
1996b; Pankratov et al., 2007; reviewed in Cunha, 2008). Thus, as
previously found in a different set of hippocampal synapses (Rebola
et al., 2008), the results presented in this study show that A2AR are
selectively engaged during synaptic plasticity, whereas the activation
of A1R could instead act as a general threshold barrier that tonically
restrains synaptic transmission and, to a lower extent, LTP (reviewed
in Cunha, 2008). Notably, these different roles of A1R and A2AR in
the modulation of synaptic transmission and plasticity are increased
with ageing. In the case of A2AR, their tonic activation by
endogenous adenosine becomes increasingly evident upon ageing
only upon LTP and not under basal stimulation conditions. In
contrast, A1R seem to be selectively involved in the modulation of
basal synaptic transmission at all tested ages but lose their tonic
effect on LTP, which is only observed in young animals. Hence, in
aged rats there is a more evident functional segregation of the roles
Fig. 5. Increased expression of A2A receptor (A2AR) mRNA and increased association of A2AR to glutamatergic nerve terminals in the hippocampus of aged rats.
(A, B) Expression of A1R (A) and A2AR (B) in the hippocampus of rats (2–3, 6–8 and 18–20 months old). A1R and A2AR mRNA levels (copies ⁄ lL) were
determined with qRT-PCR and normalized to the level of b-actin mRNA. Bars represent mean ± SEM from ﬁve different rats from each age group, run in triplicate.
(C, D) Double immunocytochemical staining of A1R (C) or A2AR (D) together with a glutamatergic marker (vesicular glutamatergic transporter type 1, vGluT1) in
hippocampal nerve terminals obtained from 2–3-month-old (top photographs in each panel), 6–8-month-old (middle photographs in each panel) or 18–20-month-old
rats (bottom photographs in each panel). (E, F) The fraction of glutamatergic terminals (i.e. vGluT1-positive) containing A1R (E) or A2AR (F). Data are mean ± SEM
of n = 4–6 rats in each age group. *P < 0.05 between the indicated bars using the Newman–Keuls test applied after anova. Note that there is always a different
density of plated nerve terminals in different experiments (each pair of pictures corresponds to a different experiment) and, hence, attention should be focused on the
co-localization of the two ﬂuorophores rather than the absolute value of each ﬂuorophore.
Ageing, adenosine and LTP 19
ª 2011 The Authors. European Journal of Neuroscience ª 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 34, 12–21
played by A1R and A2AR: whereas the former selectively modulate
basal transmission, the latter selectively modulate LTP. Further studies
will be required to determine if these changes in the density and
function of the adenosine neuromodulation system contribute to age-
related dysfunction or represent an adaptive mechanism to counteract
the different and heterogeneous modiﬁcations of neuronal circuits on
ageing (e.g. Barnes, 1994). Further studies should also be directed to
explore if these age-related changes in adenosine neuromodulation are
also found at other synapses, for instance at CA3 synapses, where both
A1R and A2AR are also known to modulate synaptic plasticity (Moore
et al., 2003; Rebola et al., 2008).
It is interesting to note that this age-related segregation of the roles of
A1R and A2AR is also accompanied by a disappearance of a close
interplay between A1R and A2AR. Thus, we observed that in aged rats
the enhanced tonic activation of A2AR by endogenous adenosine was
independent of A1R function (i.e. SCH58261 decreased the magnitude
of LTP irrespective of the presence of DPCPX), in accordance with
previous neurochemical data (Lopes et al., 1999) indicating that the
role of A2AR in the modulation of hippocampal physiology changes
upon ageing from a modulator of other modulators (i.e. A1R in adult
rats) to a direct modulator of synaptic function in aged rats.
Furthermore, it should be noted that the modiﬁcations of A2AR seem
to bemore evident in aged rats. Thus, it is in aged rats that we observe an
enhanced expression of A2AR mRNA, a greater association of A2AR
with glutamatergic nerve terminals and a greater impact of A2AR to
modulate LTP. This is in accordance with previous studies showing that
the ontogenic modiﬁcations of A2AR and A1R in the hippocampus seem
to differ: whereas the enhanced density of A2AR was only observed in
aged rats (Rebola et al., 2003b), there was an age-dependent contin-
uous decrease of the density of A1R (Cunha et al., 2001b).
The presently observed greater effects of tonic A2AR activation on
the modulation of LTP in hippocampal slices of aged rats are
particularly relevant in view of the ability of A2AR antagonists to
recover and normalize age-related memory deﬁcits (Prediger et al.,
2005). In fact, A2AR antagonists recovered the deﬁcient social
recognition memory of aged rats to levels of performance similar to
those recorded in adult rats, whereas A2AR antagonists did not modify
memory performance in adult rats (Prediger et al., 2005). However, the
relationship between the presently observed effects of A2AR antago-
nists on LTP and the ability of A2AR antagonists to normalize memory
performance should be considered with care for two reasons: (i) the
effects of A2AR on memory were observed upon prolonged adminis-
tration of A2AR antagonists, whereas we now report acute effects of
A2AR antagonists on LTP; and (ii) the ability of A2AR to control
memory performance was observed in whole animals, whereas we now
report effects of A2AR in isolated hippocampal slices, which only
partially (at best) recapitulate the functioning of brain circuits.
Furthermore, the relationship between LTP and memory is certainly
complex, because it involves the correct processing of memory-related
information, which is dependent on deﬁning the salience of information
to be encoded, a process that requires not only potentiation of synaptic
strength but also depression and depotentiation (e.g. Martin et al.,
2000; Govindarajan et al., 2006; Kemp & Manahan-Vaughan, 2007),
both homosynaptic and heterosynaptic (e.g. Remondes & Schuman,
2004; Izumi & Zorumski, 2008). In this context, A2AR were proposed
to have a normalizing, rather than a purely facilitatory, role on synaptic
plasticity and memory (discussed in Cunha & Agostinho, 2010).
Recently, great interest was raised about a possible protective effect of
caffeine, the most widely consumed psychotropic drug in the world,
against cognitive decline and dementia, based on both animal studies and
epidemiological data (de Mendonc¸a & Cunha, 2010). Caffeine is a non-
selective antagonist for both adenosine A1R and A2AR and its impact on
synaptic plasticity is qualitatively similar to that caused by A2AR blockade
(Costenla et al., 2010). The increased role for A2AR in the modulation of
synaptic plasticity in aged subjects could help to explain the reported
beneﬁts for caffeine in memory and cognition speciﬁcally in aged animals
(Costa et al., 2008) and old people (e.g. Ritchie et al., 2007).
In conclusion, the present results show that the role of adenosine
receptors is modiﬁed upon ageing. The observed predominant effect of
adenosine A2AR to modulate LTP in aged rats is in notable agreement
with the ability of A2AR antagonists to normalize the age-related
decline of memory performance, and should encourage testing a
possible effect of adenosine A2AR antagonist to prevent or ameliorate
cognitive deﬁcits in the elderly.
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